ctDNA Patterns Track Genomic Risk and Treatment Response in Advanced Breast Cancer
An exploratory BRIGHT-2 trial analysis associated longitudinal ctDNA patterns with prognosis, molecular response and candidate resistance alterations in advanced breast ...
